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ABSTRACT: Sialylated oligosaccharides contribute 12.6−21.9% of total free oligosaccharides in human milk (hMOS). These
acidic hMOS possess prebiotic properties and display antiadhesive effects against pathogenic bacteria. Only limited amounts of
sialylated hMOS are currently available. The aim of our work is to enzymatically synthesize sialylated oligosaccharides
mimicking hMOS functionality. In this study, we tested mixtures of glucosylated-lactose (GL34), galactosylated-lactulose
(LGOS), and galacto-oligosaccharide (Vivinal GOS) molecules, as trans-sialylation acceptor substrates. The recombinant trans-
sialidase enzyme from Trypanosoma cruzi (TcTS) was used for enzymatic decoration, transferring (α2→3)-linked sialic acid
from donor substrates to nonreducing terminal β-galactopyranosyl units of these acceptor substrates. The GL34 F2 2-Glc-Lac
compound with an accessible terminal galactosyl residue was sialylated efficiently (conversion degree of 47.6%). TcTS sialylated
at least 5 LGOS structures and 11 Vivinal GOS DP3−4 compounds. The newly synthesized sialylated oligosaccharides are
interesting as potential hMOS mimics for applications in biomedical and functional-food products.
KEYWORDS: sialic acid, trans-sialidase, Trypanosoma cruzi, trans-sialylation, lactulose, galactooligosaccharides
■ INTRODUCTION
In human milk, free oligosaccharides constitute the third-most-
abundant component after lactose and fat. Human milk
oligosaccharides (hMOS) represent lactose molecules elon-
gated with N-acetylglucosamine (GlcNAc), galactose (Gal),
fucose (Fuc), and N-acetylneuraminic acid (Neu5Ac) with
various glycosidic-linkage types.1 Sialic acid can be coupled to
galactose residues in hMOS with (α2→3) or (α2→6) linkages
and to GlcNAc with (α2→6) linkages. These sialylated
oligosaccharides contribute 12.6−21.9% of total hMOS.2
There is increasing evidence for positive functional effects
from this group of acidic oligosaccharides on human health.3−5
Specific hMOS structures, namely, disialyllacto-N-tetraose and
2′-fucosyllactose, prevented and reduced necrotizing enter-
ocolitis (NEC) in neonatal rats and thus may be used to
prevent NEC in formula-fed infants.6,7 Preventive effects
against NEC were also observed with a Sia-GOS mixture,
particularly with disialylated GOS.7,8 3′-Sialyllactose stimulates
growth of various Bif idobacterium strains, including the infant-
gut-related Bif idobacterium longum subsp. infantis.9 Sialylated
oligosaccharides also prevent intestinal attachment of
pathogens by acting as receptor analogues, competing with
epithelial ligands for bacterial binding.10−14 Compared with
human milk, free oligosaccharides in the milk of domesticated
animals are much less abundant.15 Bovine milk, for instance,
has only trace amounts of milk oligosaccharides.16,17 The
natural scarcity of these highly bioactive sialylated oligosac-
charides stimulated us to study the possible synthesis of
mimics via trans-sialylation of β-galactose (β-Gal)-linked
compounds in various oligosaccharide mixtures. One example
is the Vivinal GOS mixture that is commercially used in infant
nutrition.18,19
Recently, we have reported the enzymatic synthesis of two
novel oligosaccharide mixtures (GL34 and LGOS) and their
structural characterization.20,21 GL34 is a mixture of five (α1→
2/3/4)-glucosylated lactose molecules, with a degree of
polymerization (DP) of 3−4, synthesized from sucrose as
the donor substrate by glucansucrases (Gtf180-ΔN and GtfA-
ΔN) as biocatalysts (Scheme 1).20 The GL34 mixture exhibits
selective stimulatory effects on the growth of various strains of
lactobacilli and bifidobacteria.22 LGOS is a mixture of (β1→3/
4/6)-galactosylated lactulose molecules, with one or two
galactosyl moieties, synthesized from lactulose as the donor
and acceptor substrate by wild-type and mutant β-galactosidase
enzymes from Bacillus circulans ATCC 31382 (Scheme 1).21
Previously, oligosaccharides derived from lactulose were shown
to promote the growth of bifidobacteria and to exert beneficial
effects on the digestive tract.23−26
In view of the potential functional properties of these novel
GL34 and LGOS oligosaccharides we decided to try and
further develop their structures to better mimic acidic hMOS.
In this study, trans-sialidase from Trypanosoma cruzi (TcTS)27
was employed for the trans-sialylation of oligosaccharides in
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the GL34 and LGOS mixtures. Among trans-sialidases (EC
3.2.1.18), T. cruzi trans-sialidase is one of the best-studied
enzymes.27 It plays an important role in host-cell invasion and
pathogenicity of T. cruzi because of its ability to scavenge and
transfer sialic acid to the pathogen’s extracellular mucins,
thereby hiding the pathogen from the host immune
system.28,29
TcTS catalyzes trans-sialylation reactions via a ping-pong
mechanism,30 which starts with formation of a stable sialo-
enzyme intermediate through a covalent bond with the
nucleophile Tyr342.31 This is followed by transfer of the sialic
acid to a β-Gal-linked acceptor substrate involving a
nucleophilic attack of the hydroxyl group at C3 of this β-
Gal.30 When a suitable β-Gal-linked acceptor is absent, this
enzyme catalyzes a hydrolysis reaction and sialic acid is
released.32 In case of TcTS, sialyl transfer is catalyzed with
much greater efficiency than hydrolysis.33 TcTS can use
glycoproteins or oligosaccharides as acceptor substrates, but it
only uses compounds possessing sialic acid (α2→3)-linked to a
terminal β-Gal as donor substrates.33 In previous work, we
showed that TcTS catalyzes the transfer of sialic acid from a κ-
casein-derived glyco-macropeptide (GMP) donor substrate to
galacto-oligosaccharides (GOS).8,34 However, a detailed
analysis of these monosialylated and disialylated GOS
structures was not performed. GMP is a byproduct of cheese
manufacturing and contains a high levels of O-glycans, which
carry Neu5Ac, including mainly Neu5Ac(α2→3)Gal(β1→
3)GalNAc and Neu5Ac(α2→3)Gal(β1→3)[Neu5Ac(α2→
6)]GalNAc, which can be used as donor substrates.35,36
In this study, we used the GL34 and LGOS mixtures as
acceptor substrates and GMP as the donor substrate. The
negatively charged products were fractionated using Dowex 1
× 8 chloride. Furthermore, we characterized the sialylated
GOS structures that were synthesized in our previous work8 in
more detail. The decorated GL34, GOS, and LGOS structures
were identified using high-pH anion-exchange chromatography
(HPAEC), and one-dimensional 1H nuclear-magnetic-reso-
nance spectroscopy (1D 1H NMR spectroscopy).
■ MATERIALS AND METHODS
Chemicals and Materials. Bovine κ-casein-derived glyco-macro-
peptide (GMP) was provided by the FrieslandCampina Innovation
Center. N-Acetylneuraminic acid (Neu5Ac), 2-O-(4-methylum-
belliferyl)-α-N-acetylneuraminic acid (4MU-Neu5Ac), and N-
acetylneuraminyl(α2→3)lactose (3′-SL) were obtained from Carbo-
synth Ltd. Neuraminidase from Clostridium perf ringens was obtained
from Roche. Synthesis of glucosylated-lactose compounds (GL34),20
galactosylated-lactulose compounds (LGOS),21 and sialylated Vivinal
GOS (DP3 and DP4) compounds8 has been reported previously.
TcTS Expression and Purification. Escherichia coli BL21 (DE3)
(Invitrogen) was used as the host for the expression of the trans-
sialidase from Trypanosoma cruzi. Precultures of E. coli BL21 (DE3)
harboring pTrcTS611/2 were cultured overnight at 30 °C.37,34
Terrific broth (TrB) with 12 g of tryptone, 24 g of yeast extract, 4 mL
of glycerol, and 100 μg mL−1 ampicillin was inoculated with 1%
preculture at 30 °C and 200 rpm. Expression of trans-sialidase was
induced using 0.2 mM isopropyl β-D-thiogalactopyranoside (IPTG)
when the cell density reached A600 = 0.4−0.6. Cultivation was
continued at 18 °C for 4 h. The cells were collected by centrifugation
(10 min, 4 °C, 10 000g) and washed with 50 mM Tris-HCl buffer
Scheme 1. Schematic Presentation of All Structures in the GL34 Glucosylated-Lactosea and LGOS Galactosylated-Lactuloseb
Mixtures Used20,21
aLactose is galactosyl-glucose. bLactulose is galactosyl-fructose.
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(pH 8.0). Cell resuspension by B-Per Tris solution (Thermo
Scientific, Pierce) was followed by incubation at room temperature
for 30 min. The trans-sialidase enzyme was purified with an HIS-
Select Nickel Affinity Gel (Sigma). After 1.5 h of binding at 4 °C on a
rotary shaker, the bound protein was consecutively washed with Tris-
HCl buffer (50 mM, pH 8.0) containing NaCl (0.3 M) and imidazole
(5 and 30 mM) prior to its elution with 300 mM imidazole in the
same buffer. Purified TcTS enzyme was washed and concentrated in
buffer Tris-HCl (pH 8.0) using a Millipore filter (50k).
Enzyme Incubations. TcTS (5 μg mL−1) was incubated with
various concentrations (1, 5, and 10 mM) of the GL34 mixture
(average DP3) and 67.5 mg mL−1 GMP (corresponding to 5 mM
(α2→3)-linked Neu5Ac)34 in 50 mM sodium citrate buffer (pH 5.0)
at 25 °C for 24 h. The reactions were stopped by heating at 65 °C for
10 min. Aliquots of 10 μL were diluted with 190 μL of DMSO (95%)
for HPAEC-PAD analysis.
TcTS (5 μg mL−1) was incubated with various concentrations (1,
5, 10, and 15 mM) of the LGOS mixture (average DP3) and 67.5 mg
mL−1 GMP (corresponding to 5 mM (α2→3)-linked Neu5Ac)34 in
50 mM sodium citrate buffer (pH 5.0) at 25 °C. TcTS (5 μg mL−1)
was added to the incubation mixture at t = 0 h and after each 24 h of
incubation. Aliquots of 20 μL were sampled after 24, 48, and 72 h of
incubation and mixed with 380 μL of DMSO (95%) for analysis by
HPAEC-PAD profiling. The reactions were stopped by heating at 65
°C for 10 min.
Isolation of Negatively Charged Oligosaccharides by
Dowex Chromatography. Dowex 1 × 8 chloride (Cl−) (Sigma-
Aldrich) was packed in an Econo-column (1.5 × 10 cm, Biorad) and
activated with 10 column volumes (10 CV) of NaOH 2 M (at least 1
h contact time). Before injection of samples, the column was
equilibrated with 10 CV of water. Elution of the sialylated
oligosaccharides was performed at a flow-rate of 1 mL min−1 with
Milli-Q water (MQ) and ammonium bicarbonate as eluents. After
injection, unbound compounds were removed from the column by
washing with MQ for 3 CV. Monosialylated and disialylated
oligosaccharides were eluted with 3 CV of 50 and 400 mM
ammonium bicarbonate, respectively. An extra elution step with 500
mM ammonium bicarbonate was used to wash off all remaining
sialylated structures. The collected fractions were lyophilized.
Desialylation of Sialylated Oligosaccharides. Fractions of
sialylated LGOS were treated with acetic acid (20%) for 1 h at room
temperature, which was followed by neutralization with 1 M NaOH.
Desialylated fractions were desalted using Carbograph SPE columns.
Sialylated Vivinal GOS fractions of DP3 and DP4 were desialylated
by incubation with 1 U mL−1 neuraminidase (Roche) in 0.1 M acetate
buffer (pH 5.0) at 37 °C for 24 h.
HPAEC-PAD Chromatography. Oligosaccharide mixtures were
analyzed by HPAEC-PAD profiling on a Dionex ICS-3000 system
(Thermo Scientific) equipped with a CarboPac PA-1 column (250 ×
2 mm, Dionex) and detected with a pulsed amperometric detector
(PAD) using a gold working electrode. Eluting glycans were detected
using a standard manufacturer’s quadruple-potential waveform for
detecting carbohydrates. Conversion of substrates into sialylated
compounds was estimated by comparing converted peaks with
unconverted peaks (F1 and F3 for GL34, Fru for LGOS) at different
time points, calculating depletion of peaks. A gradient of 30 to 600
mM sodium acetate in 0.1 M NaOH (0.25 mL min−1) was used for
analytical separation of acidic oligosaccharides. Another complex
gradient of eluents A (100 mM NaOH), B (600 mM NaOAc in 100
mM NaOH), C (Milli-Q water), and D (50 mM NaOAc) was used
for profiling neutral oligosaccharide mixtures as previously
described.20
NMR Spectroscopy. Structures of the transferred compounds
were determined by 1D 1H NMR recorded at a probe temperature of
25 °C on a Varian Inova 500 Spectrometer (NMR Center, University
of Groningen). The samples were exchanged twice with D2O (99.9
atom % D, Cambridge Isotope Laboratories, Inc.) with intermediate
lyophilization and then dissolved in 0.65 mL of D2O containing
acetone as the internal standard (δ 1H 2.225 ppm). Data was recorded
at 16k complex data points, and the HOD signal was suppressed using
a WET1D pulse (500 MHz spectra). MestReNova 9.1.0 (Mestrelabs
Research SL) was used to process NMR spectra, using Whittaker
Smoother baseline correction.
■ RESULTS AND DISCUSSION
Previously, N-acetylneuraminic acid (Neu5Ac) was determined
to be a major component (>99%) of the 3.6% (w/w) sialic
acid in GMP, in comparison with N-glycolylneuraminic acid
(Neu5Gc).34 A concentration of 67.5 mg mL−1 GMP,
corresponding to 5 mM (α2→3)-linked Neu5Ac, was used
as donor substrate for the incubations in this study. At this
fixed concentration of GMP as a donor substrate, the
Figure 1. HPAEC-PAD profiles of compounds in the GL34/GMP/TcTS reaction mixture (incubation at 25 °C and pH 5.0, using 10 mM GL34)
at t = 0 h (dotted line) and t = 24 h (solid line) using a CarboPac PA-1 column with gradients for (1) neutral oligosaccharides and (2) acidic
oligosaccharides.
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concentrations of the acceptor substrates necessary to obtain
their maximal conversion degrees were determined. All the
incubations were carried out under the optimal conditions for
TcTS as previously reported (in 50 mM sodium citrate buffer
pH 5.0 at 25 °C).34,38
Sialylation of GL34 by TcTS. The mixture GL34 (average
DP3) was incubated at concentrations of 1, 5, and 10 mM,
with 67.5 mg mL−1 GMP and 5 μg mL−1 TcTS at 25 °C and
pH 5.0 for 24 h. After incubation, the HPAEC-PAD profiles
showed a new peak eluting at a retention time of ∼14.5 min,
which is in the retention area of negatively charged
oligosaccharides in this gradient (Figure 1, spectrum 2).8 In
the HPAEC-PAD profile of neutral oligosaccharides, only the
F2-compound peak had a significantly decreased area (Figure
1, spectrum 1). These results suggested that F2 was used as an
acceptor substrate for trans-sialylation by TcTS. The signals of
Neu5Ac(α2→3) (H-3e at δ 2.755 and H-3a at δ 1.795) were
detected in the 1D 1H NMR spectrum of the GL34 mixture
after the trans-sialylation reaction (Figure S1). The presence of
a new signal at δ 4.212 is fitting with the 3-substitution at the
terminal galactosyl residue of F2 with Neu5Ac (Figure S1),
confirming the synthesis of Neu5Ac(α2→3)Gal(β1→4)[Glc-
(α1→2)]Glc (Scheme 2). On the basis of the HPAEC-PAD
responses, the maximal conversion of F2 into the correspond-
ing sialylated-F2 was observed with 10 mM GL34 and
calculated as 47.6%, on the basis of reduction of the F2
peak. The data shows that only F2 was used as an acceptor
substrate for trans-sialylation by TcTS. In the GL34 mixture,
F2 is the only compound with an accessible β-Gal residue at a
nonreducing terminal position (Scheme 1). TcTS was shown
Scheme 2. Schematic Presentation of the (α2→3)-Sialylation Product of F2 (GL34 Mixture) and Possible Structures of the 5−
8 (α2→3)-Sialylation Products of the LGOS Mixture
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to also glycosylate internal β-Gal residues in specific structures
(i.e., in a Gal(β1→6)Gal epitope),27,30 but these are absent in
GL34. F1 4′-Glc-Lac and F4 2,4′-Glc-Lac, the only other GL34
compounds with nonsubstituted OH-3 positions (on the
internal galactose residue, Scheme 1),20 were not used as
acceptor substrates.
Sialylation of LGOS by TcTS. Various concentrations of
the LGOS mixture (1, 5, 10, and 15 mM) were incubated with
67.5 mg mL−1 GMP as a donor substrate and with TcTS (5 μg
mL−1) at 25 °C and pH 5.0. Because of the relatively low
stability of this trans-sialidase,38 extra TcTS (5 μg mL−1) was
added to the incubation mixtures after every 24 h of
incubation. The incubation experiments were followed over
time, and the highest degree of LGOS conversion into
sialylated LGOS was ∼52% after 48 h with 1 mM LGOS
mixture (Figure 2). Conversion of LGOS was estimated by
following nonsialylated-LGOS-peak depletion over time,
assuming that all LGOS had similar response factors on the
PAD detector. At this LGOS concentration, the conversion
degree increased significantly from 37.4 to 52.0% when the
incubation lasted from 24 to 48 h (Figure 2). In all cases, the
GMP-derived Neu5Ac(α2→3) as the donor substrate was not
completely utilized, with a maximal use of 80% when incubated
with 15 mM LGOS for 24 h. Enhanced conversion degrees
were not observed when incubating other concentrations of
the LGOS mixture longer than 24 h despite renewed addition
of TcTS (Figures S2−S4).
The HPAEC-PAD profiles of the incubation mixtures with 1
mM LGOS showed development of several new peaks over
time (Figure 3). These new peaks eluted at retention times
between 12−22 min, indicating synthesis of a complex mixture
of sialylated LGOS. The negatively charged (Sia-LGOS)
oligosaccharides were separated from the neutral (LGOS)
oligosaccharides by Dowex 1 × 8 (Cl−) chromatography and
Figure 2. Conversion of the LGOS-mixture compounds into sialylated oligosaccharides at different concentrations of LGOS and various incubation
times, with renewed addition of TcTS after each 24 h. Data obtained from HPAEC-PAD responses (in duplicate).
Figure 3. HPAEC-PAD profiles of compounds in the reaction mixtures of 1 mM LGOS, 5 mM GMP-derived Neu5Ac(α2→3), and 5 μg mL−1
TcTS incubated at 25 °C and pH 5.0 for 0−72 h, with renewed addition of TcTS (5 μg mL−1) after each 24 h of incubation. Neutral LGOS and
negatively charged Sia-LGOS eluted at 2−12 and 12−18 min, respectively.
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then reanalyzed by HPAEC-PAD profiling (Figure 4). The
neutral oligosaccharides in the unbound Dowex fraction eluted
during the first 12 min in the HPAEC-PAD profile (Figure 4,
spectrum 1). The Dowex fraction that eluted with 50 mM
ammonium bicarbonate (Sia-LGOS) eluted between 12 and
18 min in the HPAEC-PAD profile (Figure 4, spectrum 2),
fitting with monosialylated structures.8 The Dowex fraction
containing disialylated structures was relatively minor, limiting
possibilities for further characterization.
The 1D 1H NMR spectrum (Figure S5) of the negatively
charged fraction revealed signals at δ 2.760 and 1.803, which
belong to the Neu5Ac H-3e and H-3a atoms, respectively, of
the Neu5Ac(α2→3) residues.39 These NMR-spectroscopy
data confirmed the sialylation of LGOS by TcTS. To identify
the compounds in the LGOS mixture that were decorated with
Neu5Ac, desialylation of these sialylated-LGOS was carried out
using 20% acetic acid.
Comparison of the HPAEC-PAD profiles of the desialyled
fraction with that of the LGOS mixture allowed identification
of at least five structures that were monosialylated by TcTS:
LGOS2a or 2b, LGOS4, LGOS5, LGOS6, and LGOS7a or 7b
(Figure 5). In the LGOS profile structures, LGOS4 and
LGOS5 are the major components. After sialylation and
desialylation, the HPAEC-PAD profile showed LGOS6 and
LGOS7 to be the predominant structures. In the LGOS
mixture, LGOS6 is only a trace peak, but in the sialylated
fraction, LGOS6 is the major structure. This indicated that the
Gal(β1→3)Gal(β1→4) epitope is very favorable for sialyla-
tion. The LGOS7 peak consisted of two structures, one with a
Gal(β1→3)Gal(β1→3) epitope and one with a Gal(β1→
4)Gal(β1→3) epitope. Although it is not possible to
distinguish between the two structures, it is likely that
structure LGOS7a, with a terminal Gal(β1→3) residue, is
the mainly sialylated LGOS7 structure. This fits with previous
results on galactosyl-lactose conversions, showing a much
higher specificity constant (kcat/kM) for the transferase reaction
to 3′-galactosyllactose than for the reactions to 4′-galacto-
syllactose and 6′-galactosyllactose.34 Closer inspection of the
1D 1H NMR profile of the Sia-LGOS fractions revealed the Bf4
signals at δ 4.200−4.211, which originate from the LGOS4,
LGOS5, LGOS6, or LGOS7 structures (slightly shifted). This
provided evidence for the presence of the LGOS4, LGOS5,
Figure 4. HPAEC-PAD profiles of the Dowex 1 × 8 (Cl−) chromatography fractions obtained by (1) MQ rinsing (neutral oligosaccharides) and
(2) elution with 50 mM ammonium bicarbonate (Sia-LGOS). The reaction mixture of 1 mM LGOS, 5 mM GMP-derived Neu5Ac(α2→3), and 10
μg mL−1 TcTS, incubated at 25 °C and pH 5.0 for 48 h, was used for Dowex chromatography.
Figure 5. HPAEC-PAD profiles of compounds in (1) 1 mM LGOS incubation mixture before purification to remove mono- and disaccharides and
(2) Sia-LGOS fraction after being desialylated by acetic acid (20%) treatment. Identified peaks are marked corresponding to the structures shown
in Scheme 2. Peak 2 corresponds to the LGOS2a or LGOS2b structure. Peak 7 corresponds to the LGOS7a or LGOS7b structure.
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Figure 6. HPAEC-PAD profiles of the Sia-GOS (A,B) DP3 and (C,D) DP4 fractions. Mono- and disialylated-GOS peaks are marked.
Figure 7. HPAEC-PAD profiles of compounds from sialylated-GOS fractions (A) DP3 and (B) DP4: (1) neutral GOS mixtures at corresponding
DP, (2) mono-Sia-GOS, and (3) di-Sia-GOS fractions after being desialylated. Identified GOS peaks are marked with numbers as used by van
Leeuwen et al.,40 corresponding with those in Scheme 3. Peak 6 corresponds to GOS6a or 6b; peak 10 corresponds to GOS10a or 10b; peak 15
corresponds to GOS15a or 15b; peak 16 corresponds to GOS16a, 16b, or 16c; and peak 18 corresponds to GOS18a or 18b.
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LGOS6, or LGOS7 compounds in the Sia-LGOS mixture.
Moreover, the 1H NMR spectrum of this mixture showed
anomeric C-1 signals (slightly shifted) at δ 4.694, 4.650, and
4.629 from the structures LGOS4−7.
In LGOS5 (Gal(β1→3)Gal(β1→4)Fru) and LGOS7a
(Gal(β1→3)Gal(β1→3)Gal(β1→4)Fru), the O-3 positions
of the internal β-Gal residues are already substituted, only the
terminal β-Gal residues of LGOS5 and LGOS7a are available
for (α2→3)-linked decoration with Neu5Ac to yield the
corresponding monosialylated oligosaccharides: Neu5Ac(α2→
3)Gal(β1→3)Gal(β1→4)Fru and Neu5Ac(α2→3)Gal(β1→
3)Gal(β1→3)Gal(β1→4)Fru (Scheme 2). The structure of
LGOS4 (Gal(β1→4)Gal(β1→4)Fru) was only monosialylated
by TcTS, although it also possesses a nonsubstituted O-3 of
the internal β-Gal residue. This was also observed for the
similar structure β4′-galactosyl-lactose, of which only the
Scheme 3. Schematic Presentation of the Possible Structures of the 16−39 (α2→3)-Sialylation Products of the Vivinal GOS
DP3 and DP4 Fractions
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terminal β-Gal residue was (α2→3)-substituted with
Neu5Ac.34 The disialylated LGOS fraction was too minor to
be elucidated. In the LGOS mixture, only LGOS1, LGOS2a,
and LGOS3, each with two terminal β-Gal residues, as well as
LGOS2b with an internal β-Gal residue (β1→6) linked with a
terminal β-Gal residue, are likely disialylated.34
Sialylation of GOS by TcTs. In our previous work, the
Vivinal GOS DP3 and DP4 fractions were sialylated using
TcTS.8 These sialylated mixtures were applied onto a Resource
Q anion-exchange-chromatography column to obtain the
separate monosialylated- and disialylated-GOS fractions,
depending on the negative charges.8 The HPAEC-PAD
profiles of the sialylated GOS DP3 fraction showed the
presence of multiple mono-Sia-GOS compounds at retention
times between 11 and 17 min and di-Sia-GOS compounds at
retention times between 16 and 23 min (Figure 6A,B).
Similarly, in the HPAEC-PAD profiles of the Sia-GOS DP4
fraction, the mono-Sia-GOS compounds eluted at retention
times between 8 and 13 min, and the di-Sia-GOS compounds
eluted at retention times between 17 and 23 min (Figure
6C,D). The Sia-GOS mixtures were incubated with neurami-
nidase from Clostridium perf ringens, which prefers to hydrolyze
(α2→3)-linkages over (α2→6)- and (α2→8)-linked sialic
acids, to remove the sialic acid groups attached to the GOS
compounds. The HPAEC-PAD profiles of the desialylated
fractions were compared with those of the Vivinal GOS
mixture, which were previously annotated,40,41 in order to
identify decorated structures (Figure 7A1,B1). In the GOS
DP3 fraction, at least five structures were monosialylated,
namely, GOS6a or 6b, GOS9, GOS10a or 10b, GOS11, and
GOS12 (Figure 7A2). At least three of these seven structures
were also found in the di-Sia-GOS fraction, namely, GOS6a or
6b, GOS9, and GOS10a or 10b (Figure 7A3). In the GOS
DP4 fraction, the structures GOS14a or 14b, GOS15, GOS16,
GOS17, and GOS18 were found to be monosialylated (Figure
7B2), and the structures GOS14a, 14b, 15, and 16 were found
to be disialylated (Figure 7B3). The possible positions of sialic
acid (α2→3)-linked to these GOS compounds are presented
in Scheme 3. As expected, the structures GOS6a, GOS9,
GOS10a or 10b, GOS14a, GOS14b, GOS15a or 15b, and
GOS16a or 16b with two unsubstituted terminal β-Gal
residues at O-3 positions were either mono- or disialylated
by TcTS.34 The disialylation of the structure GOS6b (with an
internal β-Gal residue linked (β1→6) with a terminal β-Gal
residue) by this trans-sialidase was already observed in a
previous study (Scheme 3).34 The linear Gal(β1→4)Gal
epitope present in the structures GOS11, 16c, 17, 18a, and 18b
allowed only the terminal β-Gal residue to be sialylated by
TcTS, resulting in only monosialylation for these types of
structures (Scheme 3).
Close inspection of the HPAEC-PAD profiles (Figure 7A)
showed in the Vivinal GOS DP3 fraction only trace amounts of
GOS12 (3′-galactosyllactose) and a major peak for GOS11
(4′-galactosyllactose). After desialylation of the monosialylated
DP3 pool, approximately equal amounts of GOS11 and
GOS12 were observed. This fits with observations on LGOS
and previous work, showing a higher specificity constant of
TcTS toward 3′-galactosyllactose than toward 4′-galactosyl-
lactose.34 Also, in the DP4 fraction (Figure 7B), the linear
structures with terminal Gal(β1→4) residues (GOS17 and
GOS18) showed relatively low peaks, compared with those of
the Vivinal GOS DP4 pool, whereas the branched structures
had relatively increased.
In this study, the trans-sialidase from T. cruzi was used to
transfer sialic acid to oligosaccharides (DP3−4) in GL34,
LGOS, and Vivinal GOS mixtures.8 Decorated structures were
identified by HPAEC-PAD chromatography and NMR spec-
troscopy. As expected, various compounds in these mixtures
with one or more accessible β-Gal-OH-3 groups were used as
acceptor substrates by TcTS. The F2 (2-Glc-Lac) compound
in the GL34 mixture was monosialylated, yielding α3Sia-2-Glc-
Lac with a conversion degree of 47.6%. TcTS was able to
transfer sialic acid to at least five different compounds in the
LGOS mixture with a conversion degree of up to 52%. The
conversion of galacto-oligosaccharides (GOS) with DP3−4 (3
mM GOS with 6 mM (α2→3)-linked Neu5Ac) into Sia-GOS
by TcTS was clearly lower, at about 35%, but it was obtained
under different conditions.8 The optimal concentrations of the
GL34 and LGOS mixtures for maximal conversion by TcTS
(10 μg mL−1) in the incubations with 5 mM (α2→3)-linked
Neu5Ac (from GMP) were 10 and 1 mM, respectively. In fact,
all the structures in the LGOS mixture possess terminal
nonreducing β-Gal residues, whereas only the F2 compound of
the GL34 mixture has a terminal β-Gal residue. Previously,
only lactulose was used as an acceptor substrate for a mutant
trans-sialidase Tr13 from T. rangeli.42 The GOS mixture has
been known to provide multiple C-3 hydroxyl groups and to be
an easily accessible substrate for trans-sialidase, including TcTS
(acceptor) sites.9,8,43 Our study showed that in fact most of the
GOS structures of DP3 and DP4 from Vivinal GOS were
sialylated by TcTS. Moreover, the results revealed a strong
preference for terminal β-Gal residues to be sialylated. Only
branched compounds with two nonreducing terminal β-Gal
residues were disialylated. The only exception known so far is
6′-galactosyllactose, which is linear with a specific Gal(β1→
6)Gal epitope that could be disialylated by TcTS.34 Moreover,
our study showed that structures with a Gal(β1→3) terminal
residues were more efficiently sialylated by TcTS.
In conclusion, the data show that enzymatic synthesis of
sialylated lactose- and lactulose-derived oligosaccharides, using
the TcTS enzyme and (α2→3)-Neu5Ac from GMP as a donor
substrate, yields a highly interesting variety of sialylated
oligosaccharides. This transfer of sialic acid as a functional
group is the first step in developing hMOS-mimicking
compounds. In future studies, we aim to optimize their
biosynthesis and to evaluate the potential use of these novel
compounds for pathogen inhibition and prevention of NEC.
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